HSA, O., MO, O., DP, A., & AA, O. (2026). Genetic Variations in the Dopaminergic Signaling Pathways and Their Implications for Antipsychotics Pharmacogenetics. Journal of molecular neuroscience : MN, 76(2), . https://doi.org/10.1007/s12031-026-02505-0
Chicago Style (17th ed.) CitationHSA, Olasore, Olawale MO, Asiwaju DP, and Olashore AA. "Genetic Variations in the Dopaminergic Signaling Pathways and Their Implications for Antipsychotics Pharmacogenetics." Journal of Molecular Neuroscience : MN 76, no. 2 (2026). https://doi.org/10.1007/s12031-026-02505-0.
MLA (9th ed.) CitationHSA, Olasore, et al. "Genetic Variations in the Dopaminergic Signaling Pathways and Their Implications for Antipsychotics Pharmacogenetics." Journal of Molecular Neuroscience : MN, vol. 76, no. 2, 2026, https://doi.org/10.1007/s12031-026-02505-0.